Drugs / VELGRAFT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07498218 | Mar → Oct 2026 expected | ulcer of lower limbs | Ayu, Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VELGRAFT | “The objective of this study is to evaluate the safety and efficacy of VELGRAFT in patients with chronic diabetic foot ulcers, which have attained granulation tissue.” NCT07498218 ↗ |
| Route | Topical | “VELGRAFT is applied topically.” NCT07498218 ↗ |